XT
BJDX icon

XTX Topco’s Bluejay Diagnostics BJDX Stock Holding History

XTX Topco’s Portfolio BJDX Stock Details BJDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7
Closed -$8.43K – 1882
2024
Q1 		$8.43K Buy
+7
New +$9.65K ﹤0.01% 1684

Other funds holding BJDX

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

XTX Topco's BJDX Position: Q2 2024 in Review

XTX Topco sold out of Bluejay Diagnostics (BJDX) in Q2 2024, closing a stake of 7 shares — an estimated $8.43K sold.

XTX Topco first reported a position in BJDX in Q1 2024 and held it in 1 quarter. The position peaked at $8.43K in Q1 2024. 5 funds tracked by Wall St. Rank hold BJDX as of Q2 2024.

  • XTX Topco reported no remaining Bluejay Diagnostics position as of Q2 2024 after selling out during the quarter.
  • XTX Topco sold 7 Bluejay Diagnostics shares in Q2 2024, an estimated $8.43K.
  • XTX Topco first reported a position in Bluejay Diagnostics in Q1 2024 and held it in 1 quarter.
  • XTX Topco's Bluejay Diagnostics position peaked at $8.43K in Q1 2024.
  • 5 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q2 2024.

Based on XTX Topco's 13F filing for Q2 2024, filed 12 Aug 2024.